DE69917883D1 - Phospholipid-beschichtete mikrokristalle für die kontrollierte abgabe von pharmakologisch aktiven verbindungen und verfahren zu deren herstellung und verwendung - Google Patents
Phospholipid-beschichtete mikrokristalle für die kontrollierte abgabe von pharmakologisch aktiven verbindungen und verfahren zu deren herstellung und verwendungInfo
- Publication number
- DE69917883D1 DE69917883D1 DE69917883T DE69917883T DE69917883D1 DE 69917883 D1 DE69917883 D1 DE 69917883D1 DE 69917883 T DE69917883 T DE 69917883T DE 69917883 T DE69917883 T DE 69917883T DE 69917883 D1 DE69917883 D1 DE 69917883D1
- Authority
- DE
- Germany
- Prior art keywords
- microcrystals
- active compounds
- mum
- pharmacologically active
- phospholipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/190,049 US6180136B1 (en) | 1998-11-10 | 1998-11-10 | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
US190049 | 1998-11-10 | ||
PCT/US1999/026452 WO2000027369A1 (en) | 1998-11-10 | 1999-11-08 | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69917883D1 true DE69917883D1 (de) | 2004-07-15 |
DE69917883T2 DE69917883T2 (de) | 2005-06-02 |
Family
ID=22699828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69917883T Expired - Fee Related DE69917883T2 (de) | 1998-11-10 | 1999-11-08 | Phospholipid-beschichtete Mikrokristalle für die länger anhaltende Freisetzung von pharmakologisch aktiven Verbindungen und Verfahren zu deren Herstellung und deren Verwendung |
Country Status (9)
Country | Link |
---|---|
US (2) | US6180136B1 (de) |
EP (1) | EP1043978B1 (de) |
JP (1) | JP3831613B2 (de) |
AT (1) | ATE268594T1 (de) |
AU (1) | AU760111B2 (de) |
CA (1) | CA2315975C (de) |
DE (1) | DE69917883T2 (de) |
ES (1) | ES2221484T3 (de) |
WO (1) | WO2000027369A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060002959A1 (en) * | 1996-11-14 | 2006-01-05 | Government Of The United States | Skin-sctive adjuvants for transcutaneous immuization |
US6797276B1 (en) * | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
US20060002949A1 (en) * | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
US5980898A (en) * | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
US20040258703A1 (en) * | 1997-11-14 | 2004-12-23 | The Government Of The Us, As Represented By The Secretary Of The Army | Skin-active adjuvants for transcutaneous immunization |
US7101575B2 (en) * | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
ES2211151T3 (es) * | 1998-08-19 | 2004-07-01 | Skyepharma Canada Inc. | Dispersiones acuosas inyectables de propofol. |
AU4188100A (en) * | 1999-04-08 | 2000-11-14 | Gregory M. Glenn | Dry formulation for transcutaneous immunization |
DE60000622T2 (de) * | 1999-06-10 | 2003-02-27 | Max Planck Gesellschaft | Einkapselung von kristallen mit mehrschichtigem überzug |
US8404217B2 (en) * | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
US6955908B1 (en) * | 2000-06-21 | 2005-10-18 | Lambl Barbara B | Organism associated with nongonococcal urethritis |
PT1372708E (pt) * | 2001-02-13 | 2008-09-29 | Us Gov Sec Army | Vacina para imunização transcutânea |
IN188924B (de) * | 2001-03-01 | 2002-11-23 | Bharat Serums & Vaccines Ltd | |
DE10139965B4 (de) * | 2001-08-14 | 2005-12-29 | Biotest Ag | Gammasterilisierbares Kulturmedium zum Nachweis von Hefen und Pilzen |
US7125568B2 (en) * | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
DE10149674A1 (de) | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
US20030232340A1 (en) * | 2002-06-13 | 2003-12-18 | David Anderson | Nanoporous particle with a retained target |
KR20040015622A (ko) * | 2002-08-13 | 2004-02-19 | 대한뉴팜(주) | 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물 |
UY27939A1 (es) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US6936273B2 (en) * | 2002-12-20 | 2005-08-30 | Idexx Laboratories, Inc. | Liposomal analgesic formulation and use |
DE602004016292D1 (de) * | 2003-01-20 | 2008-10-16 | Auriga Internat S A | Verwendung einer zusammensetzung mit vitamin k1-oxid oder einem derivat daraus zur behandlung und/oder vorbeugung von hautverletzungen bei säugern |
EP1568369A1 (de) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen |
DE102004013637A1 (de) * | 2004-03-19 | 2005-10-13 | Capsulution Nanoscience Ag | Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln |
DE102004021281A1 (de) * | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
US7444197B2 (en) * | 2004-05-06 | 2008-10-28 | Smp Logic Systems Llc | Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes |
DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
BRPI0515181A (pt) * | 2004-09-13 | 2008-07-22 | Bharat Serums & Vaccines Ltd | composição de óleo-em-água estéril para administração intravenosa, uso de um monoglicerìdeo e processo de preparação de uma composição para administração intravenosa |
EP1871365A2 (de) * | 2005-04-12 | 2008-01-02 | Romark Laboratories, L.C. | Verfahren zur behandlung von erkrankungen durch hemmung der funktion von molekularen chaperonen wie protein disulfid-isomerasen, diese enthaltende pharmazeutische zusammensetzungen und screening-verfahren zur identifizierung von therapeutischen mitteln |
JP2009510007A (ja) * | 2005-09-30 | 2009-03-12 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | メロキシカムを含む医薬調製 |
ES2422556T3 (es) * | 2006-01-09 | 2013-09-12 | Romark Lab Lc | Tratamiento de hepatitis vírica |
US8642062B2 (en) | 2007-10-31 | 2014-02-04 | Abbott Cardiovascular Systems Inc. | Implantable device having a slow dissolving polymer |
US7828996B1 (en) | 2009-03-27 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Method for the manufacture of stable, nano-sized particles |
CN102647971B (zh) | 2009-10-12 | 2016-03-16 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 用于包含美洛昔康的组合物的容器 |
AU2010347598B2 (en) | 2010-03-03 | 2014-11-27 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
CN102302456B (zh) * | 2011-07-26 | 2014-03-12 | 武汉回盛生物科技有限公司 | 一种动物专用磷酸替米考星微球的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4528193A (en) * | 1978-12-27 | 1985-07-09 | A. Natterman & Cie. Gmbh | Inflammation-preventing pharmaceutical composition of oral administration |
DE2914788A1 (de) | 1979-04-11 | 1980-10-16 | Nattermann A & Cie | Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung |
DE3022136C2 (de) * | 1980-06-13 | 1986-07-17 | A. Nattermann & Cie GmbH, 5000 Köln | Verfahren zum Abfüllen von Phospholipide enthaltenden pharmazeutischen Massen in Hartkapseln |
US4847015A (en) * | 1986-02-10 | 1989-07-11 | Kewpie Kabushiki Kaisha | Process for producing egg yolk lecithin having reduced PE content and/or containing substantially no impurities |
DE3608455A1 (de) * | 1986-03-14 | 1987-09-17 | Nattermann A & Cie | Phospholipidhaltige produkte, deren herstellung und verwendung |
CA1338736C (fr) | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
JPH01131189A (ja) * | 1987-11-17 | 1989-05-24 | Nippon Oil & Fats Co Ltd | ドコサヘキサエン酸含有リン脂質の製造法 |
JPH02132736A (ja) | 1988-11-14 | 1990-05-22 | Toshiba Corp | 大電力クライストロン |
US5091187A (en) | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
US5091188A (en) | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
US5660854A (en) | 1994-11-28 | 1997-08-26 | Haynes; Duncan H | Drug releasing surgical implant or dressing material |
-
1998
- 1998-11-10 US US09/190,049 patent/US6180136B1/en not_active Expired - Fee Related
-
1999
- 1999-11-08 ES ES99971704T patent/ES2221484T3/es not_active Expired - Lifetime
- 1999-11-08 AT AT99971704T patent/ATE268594T1/de not_active IP Right Cessation
- 1999-11-08 WO PCT/US1999/026452 patent/WO2000027369A1/en active IP Right Grant
- 1999-11-08 AU AU14735/00A patent/AU760111B2/en not_active Ceased
- 1999-11-08 DE DE69917883T patent/DE69917883T2/de not_active Expired - Fee Related
- 1999-11-08 EP EP99971704A patent/EP1043978B1/de not_active Expired - Lifetime
- 1999-11-08 CA CA002315975A patent/CA2315975C/en not_active Expired - Fee Related
- 1999-11-08 JP JP2000580600A patent/JP3831613B2/ja not_active Expired - Fee Related
-
2000
- 2000-07-25 US US09/624,556 patent/US6423338B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1043978B1 (de) | 2004-06-09 |
ATE268594T1 (de) | 2004-06-15 |
AU1473500A (en) | 2000-05-29 |
AU760111B2 (en) | 2003-05-08 |
JP2002529400A (ja) | 2002-09-10 |
DE69917883T2 (de) | 2005-06-02 |
EP1043978A1 (de) | 2000-10-18 |
WO2000027369A1 (en) | 2000-05-18 |
CA2315975A1 (en) | 2000-05-18 |
CA2315975C (en) | 2009-01-13 |
ES2221484T3 (es) | 2004-12-16 |
US6180136B1 (en) | 2001-01-30 |
US6423338B1 (en) | 2002-07-23 |
JP3831613B2 (ja) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69917883D1 (de) | Phospholipid-beschichtete mikrokristalle für die kontrollierte abgabe von pharmakologisch aktiven verbindungen und verfahren zu deren herstellung und verwendung | |
DE3873410D1 (de) | Formulierung zur oralen arzneistoffabgabe, sowie verfahren zu deren herstellung. | |
ATE370707T1 (de) | Zahnärztliche fräsrohlingsanordnung sowie verfahren zu deren herstellung | |
BR9808429A (pt) | Composição farmacêutica e processo para a sua preparação. | |
TR201910177T4 (tr) | Bir sinakalset HCl içeren hızlı çözünme formülasyonu. | |
ATE378062T1 (de) | Mischmicell-arzneistoffverabreichungssystem und verfahren zu dessen herstellung | |
DE60023841D1 (de) | Verfahren zur herstellung alkylierter salicylamide | |
DE60305475D1 (de) | Verfahren und vorrichtung zur herstellung von kapseln | |
BR9612291A (pt) | Forma de dosagem sólida bioadesiva | |
DE69415679D1 (de) | Nichtfaseriges poröses material, wundverband aus diesem sowie ein verfahren zu seiner herstellung | |
ATE387898T1 (de) | Abgabesystem und herstellungsverfahren für ein abgabesystem | |
ID27377A (id) | Bentuk baru dari irbesartan, proses pembuatannya dan komposisi farmasi yang mengandung irbesartan tersebut | |
DE69510928D1 (de) | Heterocyclische verbindungen, ihre herstellung und verwendung | |
BR0110618A (pt) | Composição farmacêutica similar a gel para administraçâo subcutânea compreendendo ácidos bis-fosfÈnicos ou seus sais | |
AR020780A1 (es) | Composicion farmaceutica de liberacion sostenida, y metodo para liberar un agente farmaceuticamente activo | |
FR2816507B1 (fr) | Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules | |
CA2355077A1 (en) | Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same | |
WO2008087323A8 (fr) | Forme galenique pour l'administration par voie trans-muqueuse de paracetamol | |
PT1051159E (pt) | Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose | |
ATE270665T1 (de) | Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel | |
ATE309788T1 (de) | Mikropartikel mit verbessertem freisetzungsprofil und verfahren zu deren herstellung | |
DE60203881D1 (de) | Verfahren zum herstellen von körperpflegemitteln | |
DE50208851D1 (de) | Gelierzucker und verfahren zu dessen herstellung | |
DE69911224D1 (de) | Geschmacksmaskierte kautablette mit sofortiger wirkstofffreisetzung sowie herstellungsverfahren | |
IT1272990B (it) | "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |